Accelerate COVID-19 research with new insight from world-class proteomics

Gaining actionable insights into a new disease is a significant challenge, especially under the time pressure of a global pandemic. What if you could use an open hypothesis approach that allowed you to rapidly study the plasma proteome in a robust and high throughput mode to find correlations between protein biomarkers and disease, understand what biological pathways are involved and identify markers of disease stage, prognosis severity and immunological response etc? Together with analysis of related comorbidities, this could enable the assessment of multiple risk factors for severe COVID-19, provide tools with which to monitor patients and identify potential new drug targets.